39,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
20 °P sammeln
  • Format: PDF

“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world. Just take a brief look at the business class occupancy of flights from Europe, North America or Japan to major Chinese cities: This gives you a glimpse of how business people are attracted by steady growth rates of 6 percent to 10 percent. It also indicates how much attention is given to a market featuring 1.3 billion potential consumers and a government committed to rapidly changing the country from an agricultu- dominated developing country into one of…mehr

Produktbeschreibung
“Don’t miss out on China!” and “What are you doing about China?” Catch phrases like these are spreading among managers all over the world. Just take a brief look at the business class occupancy of flights from Europe, North America or Japan to major Chinese cities: This gives you a glimpse of how business people are attracted by steady growth rates of 6 percent to 10 percent. It also indicates how much attention is given to a market featuring 1.3 billion potential consumers and a government committed to rapidly changing the country from an agricultu- dominated developing country into one of the world’s economic powerhouses. Most of the global industrial players have had economic ties with China for decades already, but they were further strengthened after the country’s opening to the world in the early 1980s. Furthermore, China’s accession to the World Trade Or- nization is expected to catapult this already surging economy into another sphere of development.
Autorenporträt
At detailed look at China s increasingly important chemical and pharmaceutical industry. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharma companies. Numerous case examples describe how Western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China. The book also analyzes the threat of Western companies in their home markets by Chinese competitors.
Rezensionen
From the reviews: "China, with its potential market of 1.3 billion consumers, has resurrected the western world's stagnant economic outlook. ... This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)